Bausch Health Companies | VRX - Operating Expenses

Stock Price
7.69
Daily Change
0.10 1.32%
Monthly
9.54%
Yearly
2.12%
Q2 Forecast
7.53

Bausch Health Companies reported $2.08B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Amgen USD 5.9B 773M Dec/2025
ANI Pharmaceuticals USD 217.93M 287.88M Dec/2025
Aurora Cannabis CAD 129.98M 16.05M Dec/2025
Bausch Health Companies USD 2.08B 113M Dec/2025
Biogen USD 1.88B 81.4M Sep/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Canopy Growth CAD 87.2M 6.22M Dec/2025
Corcept Therapeutics USD 197.64M 219K Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Drreddys Laboratories INR 72.94B 4.33B Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
Nektar Therapeutics USD 40.9M 44.19M Dec/2025
Novo Nordisk DKK 46.76B 3.99B Dec/2025
Pacira USD 193.68M 27.32M Dec/2025
Perrigo USD 1.03B 75.3M Dec/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 200.95M 6.51M Dec/2025
Supernus Pharmaceuticals USD 197.75M 54.54M Dec/2025
Vertex Pharmaceuticals USD 1.93B 89.1M Dec/2025
Zoetis USD 1.55B 3.85B Dec/2025